Pfizer COVID-19 shot effective for people with chronic diseases: Israel study

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

The COVID-19 vaccine developed by Pfizer and BioNTech is effective at preventing symptomatic and severe disease in people with some chronic ...

A teenager receives a vaccination against the coronavirus disease , in Tel Aviv, Israel, on Jan 24, 2021. REUTERS/Ronen Zvulun)JERUSALEM: The COVID-19 vaccine developed by Pfizer and BioNTech is effective at preventing symptomatic and severe disease in people with some chronic illnesses, like diabetes and heart disease, the biggest real-world study showed on Thursday .

It was more than 90 per cent effective against severe disease for people with type 2 diabetes, heart or cerebrovascular disease and 100 per cent for people suffering from immunodeficiency. "Protection is mildly reduced among patients with several co-morbidities. These results are very encouraging, as they suggest that most COVID-19 cases will be prevented by vaccination even in the elderly and chronically ill," said Ran Balicer, Clalit's chief innovation officer.

Until mid-April, Israel has documented 98 per cent fewer coronavirus cases, 93 per cent fewer critically ill and 87 per cent fewer COVID-19 deaths, according to Eran Segal, data scientist at the Weizmann Institute of Science. Danny Altmann, an immunology professor at the Imperial College London, said the study was among the first real world research to offer such granular data into vaccinated subgroups.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

😆😆😆😆 effectively dead

去年生产的对变异新冠病毒无效。

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Risk from COVID-19 variants remains after first Pfizer COVID-19 vaccine, UK study findsLONDON :A single dose of Pfizer's coronavirus vaccine may not generate a sufficient immune response to protect against dominant new variants, ... 所以那些還沒有完成接種第二針疫苗的國家是不能對印度,巴基斯坦,尼泊爾,斯里蘭卡開放的。 3rd and 4th doses coming your way. Then 5th and 6th......... WHILE VIRYS MUTATES
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Israel examining heart inflammation cases in people who received Pfizer COVID-19 shotIsrael's Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer's COVID-19 ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Israel examining heart inflammation cases in people who received Pfizer COVID-19 shotIsrael's Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer's COVID-19 ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Israel examining heart inflammation cases in people who received Pfizer-BioNTech COVID-19 vaccineIsrael's Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer's COVID-19 ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

7 more workers at Westlite Woodlands dorm test positive for Covid-19, bringing total to 19SINGAPORE — Seven more workers from the Westlite Woodlands dormitory have tested positive for Covid-19 after recovering from past infections, bringing the total number of cases at the dormitory to 19, the Ministry of Manpower clarified on Thursday (April 22). Must have returned India and back... It's normal. Vaccine working. Give it some time. Ensure that they spread more to do litmus test to the said vaccine.
Source: TODAYonline - 🏆 1. / 99 Read more »